Skip to main content
. 2019 Jan 27;20(3):530. doi: 10.3390/ijms20030530

Figure 4.

Figure 4

PKA level change after selected natural compounds’ treatment. Pancreatic cells were treated with and 16-hydroxycleroda-3,13-dien-15,16-olide (HCD & 16H) with/without GLP-1 (natural incretin) and exendin-4 (Ex-4, GLP-1 analogue) and PKA levels analyzed. PKA level was normalized with GAPDH and mean ± SD shown from three independent experiments. * p < 0.05 was marked in the column significantly different to the untreated control.